156 related articles for article (PubMed ID: 16822723)
1. Type-2 diabetes mellitus related cardiovascular risk: new options for interventions to reduce risk and treatment goals.
Hobbs FD
Atheroscler Suppl; 2006 Aug; 7(4):29-32. PubMed ID: 16822723
[TBL] [Abstract][Full Text] [Related]
2. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
Gotto AM
Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain.
Lahoz-Rallo B; Blanco-Gonzalez M; Casas-Ciria I; Marín-Andrade JA; Mendez-Segovia JC; Moratalla-Rodriguez G; Quintero-Dominguez R; Ramirez-Raya M; Guerrero-Pinedo MJ; Aguilar-Diosdado M
Diabetes Res Clin Pract; 2007 Jun; 76(3):436-44. PubMed ID: 17064808
[TBL] [Abstract][Full Text] [Related]
4. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
6. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
7. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
8. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
11. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
12. Improving macrovascular outcomes in type 2 diabetes: Outcome studies in cardiovascular risk and metabolic control.
Schneider CA
Curr Med Res Opin; 2006; 22 Suppl 2():S15-26. PubMed ID: 16914072
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome.
Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
[TBL] [Abstract][Full Text] [Related]
15. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
Ceriello A; Davidson J; Hanefeld M; Leiter L; Monnier L; Owens D; Tajima N; Tuomilehto J;
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):453-6. PubMed ID: 16934443
[TBL] [Abstract][Full Text] [Related]
16. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
Sinclair G; Kerr A
N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
[TBL] [Abstract][Full Text] [Related]
17. The influence of socioeconomic factors on cardiovascular disease risk factors in the context of economic development in the Samoan archipelago.
Ezeamama AE; Viali S; Tuitele J; McGarvey ST
Soc Sci Med; 2006 Nov; 63(10):2533-45. PubMed ID: 16876925
[TBL] [Abstract][Full Text] [Related]
18. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Lorenzo C; Williams K; Hunt KJ; Haffner SM
Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of hypertension in patients with type 2 diabetes.
Thomas MC; Atkins R
Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
[TBL] [Abstract][Full Text] [Related]
20. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.
Smith SC; Haslam D
Curr Med Res Opin; 2007 Jan; 23(1):29-47. PubMed ID: 17261236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
